AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05788835 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: DEB-TACE and HAIC
Description: Drug-eluting bead transarterial chemoembolization sequential Hepatic Artery Chemotherapy Infusion
Study NCT04783441 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dexcom G6
Description: access to continuous glucose monitoring in the Dexcom G6 arm 24/7
Study NCT04783441 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Dexcom G6 blinded sensor
Description: retrospective access to continuous glucose profile after 10 days of wear
Study NCT05788835 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: DEB-TACE
Description: Drug-eluting bead transarterial chemoembolization
Study NCT01874314 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SQ109
Description: 300mg or 450mg of SQ109 administered orally, once daily for 7 days.
Study NCT05561907 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical gastrojejunostomy (SGJ)
Description: Laparoscopic gastrojejunostomy
Study NCT05561907 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic gastrojejunostomy (EGJ)
Description: Endoscopic ultrasound (EUS) guided gastrojejunostomy
Study NCT05450354 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: Questionnaires will be completed only once :~* Neurodevelopment in children: Kiddie Schedule for Affective Disorders and Schizophrenia, Present and Lifetime version (K-SADS-PL-5), the Social Responsiveness Scale (SRS), The Children's Communication Checklist-2 (CCC-2), The Autism-Tics, ADHD and Other Comorbidities Inventory (A-TAC), CONNERS-3, Sensory Profile 2 (DUNN)~* Psychopathological profile of the child by evaluating the presence of psychotic symptoms: K-SADS-PL-5, Prodromal Questionnaire (F PQ16)~* Presence of mood and anxiety disorders: Child Depression Inventory (CDI), Revised Children's Manifest Anxiety Scale (RCMAS)~* Presence of sleep disorders: Children's Sleep Habits Questionnaire (CSHQ). The K-SADS-PL-5 will only be completed by subjects who have attempted suicide after the start of the study; it requires a semi-structured interview of the child by a child psychiatrist and cannot be done remotely. The other scales will be completed by all included subjects.
Study NCT05450354 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Determination of attachment style : Adolescent Relationship Scale Questionnaire (ARSQ). The questionnaire will be completed only once.
Study NCT01874314 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: SQ109 Placebo
Description: Placebo is a round, coated, yellow, unscored tablet. SQ109 Placebo administered orally, once daily for 7 days.
Study NCT01874314 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moxifloxacin
Description: 400mg of moxifloxacin (positive control) administered orally, once daily for 7 days.
Study NCT04946929 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor Oral Tablet [Brilinta]
Description: Ticagrelor, 2-3mg/kg, 12h, p.o.
Study NCT04946929 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Low molecular weight heparin
Description: half amount low molecular weight heparin
Study NCT05265455 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Plant sterols 2.5 g/day
Description: Daily consumption of one stick (2.5 g of plant sterols) during lunch or dinner for 3 weeks
Study NCT05265455 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily consumption of one stick (the same matrix without plant sterols) during lunch or dinner for 3 weeks
Study NCT05673876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GDC-8264
Description: GDC-8264 tablets will be administered as per the schedule specified in the respective arms.
Study NCT05917301 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: hypofractionation
Description: This study is being done to see if hypofractionation in treating sarcoma, will also provide patients with a faster and safer treatment outcome.
Study NCT05663515 — intervention group
Intervention type: DRUG
Intervention: Exenatide
Description: All patients initiating exenatide during the study period will be identified by ATC codes and be included in the exenatide group in a hierarchical manner, regardless of previous use of non-GLP-1 RA based glucose lowering drugs.
Study NCT05663515 — intervention group
Intervention type: DRUG
Intervention: Non-GLP-1 RA based glucose lowering drugs
Description: Initiators of non-GLP-1 RA based GLDs with no use of exenatide before or during the study period.
Study NCT06623396 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: M28z1XXPD1DNR CAR
Description: Participants with esophagastric adenocarcinoma will be treated with an intraperitoneal infusion of different doses of autologous T cells that have been genetically modified ex vivo to express the M28z1XXPD1DNR CAR. The CAR T cells will be manufactured in MSK's Center for Cell Engineering.
Study NCT06686745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIM0508 Tablets
Description: Every 28 days is one cycle. Multiple dose levels of SIM0508 will be explored in dose escalation, and determine the maximum tolerated dose.
Study NCT06686745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIM0508 in combination with olaparib
Description: Every 28 days is one cycle.Multiple dose levels of SIM0508 and olaparib will be explored in dose escalation, and determine the maximum tolerated dose.
Study NCT06686745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIM0508 in combination with olaparib
Description: Every 28 days is one cycle.Patients will be administered a potential recommended dose of SIM0508 combination with olaparib established from SIM0508 combination dose escalation.
Study NCT06752148 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: neurofeedback intervention training game
Description: 1. Issuance of training equipment and training in its use: For subjects randomly assigned to the intervention group, a volunteer who has received adequate training in the use of the equipment will issue the EEG monitoring electrodes (model: HXD-1) and paired PADs, and will provide an activated account for the use of the subject only and training in its use. Subjects will be provided with a short tutorial on how to use the APP, which is very user-friendly and suitable for elderly novices. An initial training session will consist of 3 training components and will be completed with a volunteer.~2. Training programme and supervision: The closed-loop neurofeedback training will consist of 3 parts, namely Digital Meditation, Brain Training and Sleep Induction. The brain training will consist of three games: Idea Chase, Idea Magic Ball and Focused Archery. The control subjects lived a normal life before the surgery, and all subjects underwent the surgery as planned.
Study NCT06763276 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Group
Description: In the study, a 400-gram virtual reality (VR) headset with an anti-reflective lens system was used, compatible with all earphones with screens ranging from 4.5 to 7.0 inches. The virtual reality (VR) headset, which was lightweight enough for children to wear, was supported on three sides to fit securely on the children's heads and was disinfected after each use. For the experimental group, the compartment at the front of the virtual reality (VR) headset was removed. The earphone was placed into the removed compartment, which was then reinserted. Subsequently, the YouTube virtual reality (VR) feature was activated on the phone, making it ready for viewing.
Study NCT06763731 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Systane COMPLETE
Description: Preop dry eye management using Systane COMPLETE can help to optimize the ocular surface.
Study NCT04971785 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide (SEMA)
Description: Administered as subcutaneous (SC) injection
Study NCT04971785 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cilofexor (CILO)/Firsocostat (FIR)
Description: Tablets administered orally
Study NCT04971785 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTM SEMA
Description: Administered as SC injection
Study NCT04971785 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: PTM SEMA
Description: Administered as SC injection
Study NCT04971785 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: PTM CILO/FIR
Description: Tablets administered orally
Study NCT04971785 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTM CILO/FIR
Description: Tablets administered orally
Study NCT02379377 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fluorine F 18 L-glutamate Derivative 18F-FSPG
Description: Undergo 18F-FSPG PET scan
Study NCT02379377 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Carbon C 11 Acetate
Description: Undergo 11C-acetate PET scan
Study NCT02379377 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo 18F-FSPG, 11C-acetate, or 18F-FDG PET
Study NCT02379377 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02379377 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fluorine F 18 2-deoxy-2-(18F)fluoro-D-glucose
Description: Undergo 18F-FDG PET scan
Study NCT06604143 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Quality Training
Description: Participants will engage in piano playing tasks using their affected hand and fingers. The training focuses on specific aspects of finger movement, and participants will receive feedback related to their playing. They will wear a wrist brace for support, and their hand and arm positions will be monitored to ensure proper technique.
Study NCT06135311 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulse Width 260us
Description: electrodes placed per treatment arm, performed at bedtime, session time 30 min, frequency setting of 10Hz, pulse width setting 260us, intensity setting to patient's tolerance, duration 30 days
Study NCT06135311 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulse Width 50us
Description: electrodes placed per treatment arm, performed at bedtime, session time 30 min, frequency setting of 10Hz, pulse width setting 50us, intensity setting to patient's tolerance, duration 30 days
Study NCT05764343 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Immediate smoking cessation support
Description: Smoker patients with chronic airway diseases (asthma and/or COPD and/or bronchiectasis) will be evaluated for the inclusion criteria. Afterwards they will be randomized as routine support arm (as the current procedure of the care) and immediate support arm (intensive brief cessation advices following by the immediate arrangement of the appointment from the same clinic's smoking cessation service). Both arms will be followed remotely at first week and third months of the randomization regarding their quit status as well as their use of evidence based cessation treatments.
Study NCT05537207 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low level laser therapy
Description: low level laser therapy (LLLT) on the acupuncture points. inadition to non-steroidal anti-inflammatory drugs.The parameters of the laser device are wave length of 904 nm, maximum average power of 5 milli Watts, a maximum repetition rate of 5 kHz, energy of up to 30 J/cm², and energy density of 2 J/cm2
Study NCT05537207 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: non-steroidal drugs
Description: All women will receive non-steroidal anti-inflammatory drugs in the form of Brufen (Ibuprofen), 400 mg, 3 times per day after meals, for 6 weeks, as described by their gynecologist.
Study NCT04391465 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electrophysiological Pacing
Description: Assess the MCA CBF velocity response at different paced heart rates.
Study NCT06298565 — intervention group
Intervention type: BIOLOGICAL
Intervention: efgartigimod
Description: efgartigimod
Study NCT04858802 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PROPEL Contour Sinus Implant
Description: 370 mcg mometasone furoate-coated sinus implant
Study NCT04858802 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Balloon Sinus Dilation Alone
Description: No PROPEL Contour Sinus Implant
Study NCT02793492 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Misago® RX Self-expanding Peripheral Stent
Description: the Misago® RX Self-expanding Stent is a bare metal, nitinol stent
Study NCT06297200 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low-Intensity Focused Ultrasound
Description: A noninvasive brain stimulation device using low-intensity focused ultrasound (LIFU) - ultrasound will be used to test whether noninvasive brain stimulation can effect pain, craving, and anxiety.
Study NCT06297200 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low-Intensity Focused Ultrasound - sham
Description: A sham condition that will mimic the application of LIFU without actually administering any ultrasound to the brain.
Study NCT06510452 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2000 mg of Cefazolin
Description: receive 2000 mg of Cefazolin and 500 mg of Metronidazole IV dissolved in 100 ml NACL0.9%.
Study NCT06510452 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 500 mg of Metronidazole IV
Description: receive 2000 mg of Cefazolin and 500 mg of Metronidazole IV dissolved in 100 ml NACL0.9%.
Study NCT06510452 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NACL 0.9% 100 ml
Description: receive 100 ml NACL0.9% without any antibiotics in it.
Study NCT05750186 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Abdominal Massage
Description: Abdominal massage is a noninvasive application that stimulates bowel movements by applying patting, kneading and vibration movements over the abdominal wall to the area where the intestines are located. It increases peristalsis, creates a mechanical and reflex effect on the intestines, reducing the individual's feeling of pain and discomfort.
Study NCT06236139 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-STEAP1 CAR T-cells
Description: Given IV
Study NCT06236139 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo tumor biopsy
Study NCT06236139 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06236139 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo NM bone scan
Study NCT06236139 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT06236139 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT06236139 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO
Study NCT06236139 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Description: Given PO
Study NCT06236139 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV
Study NCT06236139 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Leukapheresis
Description: Undergo leukapheresis
Study NCT06236139 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT06236139 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA
Study NCT06236139 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET scan
Study NCT05362552 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Urban Afforestation Program
Description: An afforestation program based on land cultivation and transplantation of several plants for 90 minutes will be implemented.
Study NCT06395155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DHP2306R1
Description: 100mg per capsule, BID
Study NCT06395155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DHP2306R2
Description: 75mg per Tab, BID
Study NCT05548439 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VBI-2901a
Description: Intramuscular injection of VBI-2901a, an investigational trivalent coronavirus vaccine that contains three coronavirus spike proteins with aluminum phosphate adjuvant.
Study NCT04837053 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital decision aid for physicians and patients
Description: The intervention consists of three parts: (1) the EKIT tool provides a systematic presentation of individual patient and disease-specific information; (2) it visualizes the fulfilment of the indication criteria recommanded in corresponding german guideline; (3) it presents health information about total knee replacement.
Study NCT04837053 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine care
Description: Care as usual within the included study sites.
Study NCT04880226 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Magnetic Resonance Imaging (MRI)
Description: Ongoing evaluations of magnetic resonance imaging (MRI) using the Philips Ingenua 1.5T scanner associated with MRI-guided procedures (e.g. ablations or biopsies) are essential to continued procedure improvement within the newly-built hybrid procedure suite.
Study NCT04880226 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Description: Ongoing evaluations of magnetic resonance imaging (MRI) using the Philips Ingenua 1.5T scanner associated with MRI-guided procedures (e.g. ablations or biopsies) are essential to continued procedure improvement within the newly-built hybrid procedure suite.
Study NCT06604143 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Goal Training
Description: Participants will engage in piano playing tasks using their affected hand and fingers. The training emphasizes learning to play and producing music. Feedback will be provided on various aspects of performance such as speed and accuracy, but specific details about finger movement or technique will not be given. The use of a wrist brace and monitoring of hand and arm positions will be consistent with standard practice.
Study NCT06282224 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Performing endoscopic transnasal skull base surgery with AR-integrated endoscope
Description: To explore how to use augmented reality technology (AR) to highlight important anatomical structures in the neuroendoscopic field of view, optimize the endoscopic surgical field of view, make up for the shortage of simple endoscopic field of view, make it easier for surgeons to distinguish deep anatomical structures, and reduce the intraoperative and postoperative complications of transnasal endoscopic surgery.
Study NCT06654141 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: Alveolar ridge preservation using xenograft (Bio-Oss Collagen®) and implant placement at 2 different time intervals (3 and 6 months)
Study NCT06654141 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Alveolar ridge preservation
Description: Alveolar ridge preservation using xenograft (Bio-Oss Collagen®) and implant placement at 2 different time intervals (3 and 6 months)
Study NCT06662474 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 1. cognitive stimulation
Description: sudoku, word games, and painting by numbers for 30 minutes per day, three days per week, for a duration of 12 weeks
Study NCT06662474 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 2. psychoeducation and cognitive stimulation
Description: sudoku, word games, and painting by numbers for 30 minutes per day, three days per week, for a duration of 12 weeks and also hold open group meetings for psychoeducation (1 meeting every 2 weeks, 6 meetings in total)
Study NCT06662474 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 3. no intervention
Description: maintaines their lifestyle up until their inclusion in the study without following additional measures
Study NCT06088979 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TOUR006 - 20 MG
Description: TOUR006 20 MG
Study NCT06088979 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06088979 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TOUR006 - 50 MG
Description: TOUR006 - 50 MG
Study NCT06664385 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: concurrent physical exercise
Description: It consists of a periodization which consists of three moments adapted to the patient's needs distributed in 6 weeks and increasing the intensity gradually.
Study NCT06666660 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Multivitamin/Mineral supplements
Description: Each participant will be given 180 MVM tablets in bottles at baseline visit, and another 180 tablets at 6-month visit. Participants will be advised to take 1 tablet orally daily, in the morning before food. Participants will be asked to return the remainder of dispensed MVM tablets, along with the bottle when they come for visit 2 and visit 3. This is done for investigational product accounting and checking for adherence to the assigned treatment arm.